[Role of rifaximin in correction of IBS-like symptoms in patients with inflammatory bowel disease]

Eksp Klin Gastroenterol. 2013;(3):63-8.
[Article in Russian]

Abstract

One of the important problems in the treatment of patients with inflammatory bowel disease are the persistent complaints of pain, abdominal distention, frequent stools, excretion of mucus with faeces with the presence of endoscopic or roentgenologic remission in the damaged parts of gastrointestinal tract. In this review we describe possible causes of such complaints and some methods of their therapeutic correction.

Publication types

  • Review

MeSH terms

  • Abdominal Pain / drug therapy
  • Abdominal Pain / pathology
  • Abdominal Pain / physiopathology
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Inflammatory Bowel Diseases* / pathology
  • Inflammatory Bowel Diseases* / physiopathology
  • Intestinal Mucosa / pathology
  • Intestinal Mucosa / physiopathology
  • Rifamycins / therapeutic use*
  • Rifaximin

Substances

  • Gastrointestinal Agents
  • Rifamycins
  • Rifaximin